Finkelstein J A, Brown R W, Schneider L C, Weiss S T, Quintana J M, Goldmann D A, Homer C J
Program in Clinical Effectiveness, Children's Hospital, Boston, MA 02115.
Pediatrics. 1995 Mar;95(3):389-94.
To determine whether patient race or source of payment is associated with differences in the quality of inpatient and outpatient treatment for young children with asthma.
Structured medical record review.
Tertiary care pediatric hospital.
We studied 354 patients aged 1 to 6 years discharged with asthma between October 1, 1989 and September 30, 1990.
We developed indicators of the quality of asthma care provided before and during hospitalization and planned after discharge. Outpatient indicators were the use of inhaled beta-agonists and the use of preventive anti-inflammatory medications (inhaled steroids or cromolyn sodium) before admission. In-hospital indicators were the intensity of inhaled beta-agonist therapy in the emergency department and length of stay. Planning for post-hospital care was assessed by the prescription of a nebulizer for home use. We examined associations between these indicators and patient race and source of payment, and explored the influence of primary-care practice type on these associations.
After adjustment for potential confounders, we found that Hispanic patients were less likely than white patients to have taken inhaled beta-agonists before admission. Both black and Hispanic patients were less likely than white patients to have taken anti-inflammatory medications. When we adjusted for the patients' primary-care practice type, the effect of patient race did not persist for these indicators of outpatient care. We found no differences by patient race in emergency department care or length of hospital stay. However, black and Hispanic patients were much less likely to be prescribed a nebulizer for home use upon discharge. After adjustment for confounders, there were no differences in the quality of asthma care by source of payment.
We found that young children of racial minorities admitted for an asthma exacerbation were less likely to have received maximally effective preventive therapy. We also identified marked differences in the quality of care planned after hospital discharge for black and Hispanic patients, compared with white patients. Particularly in an era of health reform, attention should focus on barriers to high-quality care for underserved children, who are already at high risk for asthma-related morbidity.
确定患儿的种族或支付来源是否与幼儿哮喘住院和门诊治疗质量的差异相关。
结构化病历审查。
三级护理儿童医院。
我们研究了1989年10月1日至1990年9月30日期间因哮喘出院的354名1至6岁的患者。
我们制定了住院前、住院期间以及出院后计划提供的哮喘护理质量指标。门诊指标为入院前吸入β-激动剂的使用情况以及预防性抗炎药物(吸入性类固醇或色甘酸钠)的使用情况。住院指标为急诊科吸入β-激动剂治疗的强度和住院时间。通过开具家用雾化器的处方来评估出院后护理计划。我们研究了这些指标与患者种族和支付来源之间的关联,并探讨了初级保健实践类型对这些关联的影响。
在对潜在混杂因素进行调整后,我们发现西班牙裔患者入院前吸入β-激动剂的可能性低于白人患者。黑人和西班牙裔患者服用抗炎药物的可能性均低于白人患者。当我们对患者的初级保健实践类型进行调整后,患者种族对这些门诊护理指标的影响不再持续。我们发现患者种族在急诊科护理或住院时间方面没有差异。然而,黑人和西班牙裔患者出院时被开具家用雾化器处方的可能性要低得多。在对混杂因素进行调整后,哮喘护理质量在支付来源方面没有差异。
我们发现因哮喘加重而入院的少数族裔幼儿接受最大有效预防性治疗的可能性较小。我们还发现,与白人患者相比,黑人和西班牙裔患者出院后计划的护理质量存在显著差异。特别是在医疗改革时代,应关注为服务不足的儿童提供高质量护理的障碍,这些儿童已经面临与哮喘相关发病的高风险。